SBRT: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving SBRT

• A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
  NCT05613023 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 42 locations
• ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0
  NCT07407608 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: Male · 1 location
• Ablative SBRT in Elderly BC Patients
  NCT06523894 · Phase: Not applicable (e.g. observational or device study) · Ages: 70 Years and older · Sex: Female · 1 location
• Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer
  NCT05800223 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy
  NCT06596018 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab
  NCT04933903 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
  NCT06551207 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC
  NCT06168786 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC
  NCT06718309 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.
  NCT07717268 · Phase: Phase 2 · Ages: No age limits stated · Sex: Male · 15 locations
• Hypofractionated Expedited Radiotherapy for Men With localisEd proState Cancer
  NCT04595019 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Iadademstat + SBRT With Atezo in ES-SCLC
  NCT07113691 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE)
  NCT06825091 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 1 location
• Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer
  NCT06491472 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
  NCT05974475 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
  NCT04086290 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)
  NCT06437977 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Neoadjuvant Toripalimab Plus SBRT for Chemo-Resistant Triple-Negative Breast Cancer
  NCT07457359 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer
  NCT06671262 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: Female · 1 location
• ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
  NCT06775743 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Observational Study on Extreme Hypofractionation for Localized Prostate Cancer
  NCT05344235 · Phase: Not specified · Ages: No age limits stated · Sex: Male · 1 location
• Radiation Therapy Approaches for People With Prostate Cancer
  NCT07751159 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 7 locations
• Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
  NCT06686771 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 75 locations
• SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC
  NCT07451795 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: Male · 3 locations
• START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC
  NCT05209243 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: Male · 2 locations
• Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases
  NCT02185443 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)
  NCT06925984 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 5 locations

Common questions

How many recruiting trials involve SBRT?

27 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.